SCPX: Scorpius Holdings, Inc. Stock

by  •  • Comments Off on SCPX: Scorpius Holdings, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 0.84
Enterprise Value ($M) 11.21
Book Value ($M) 1.68
Book Value / Share 0.14
Price / Book 0.50
NCAV ($M) -34.24
NCAV / Share -2.76
Price / NCAV -0.02

Profitability (mra)
Return on Invested Capital (ROIC) -1.09
Return on Assets (ROA) -0.65
Return on Equity (ROE) -1.30

Liquidity (mrq)
Quick Ratio 0.13
Current Ratio 0.13

Balance Sheet (mrq) ($M)
Current Assets 3.26
Assets 39.18
Liabilities 37.50
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 6.24
Operating Income -32.85
Net Income -32.81
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -26.01
Cash from Investing 1.21
Cash from Financing 25.64

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
05-13 13G/A 3i, LP 4.90 5.91
09-06 13G Jaigobind Ramnarain Joseph 9.13
2024-05-21 13D/A Wolf Jeffrey Alan 9.60

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-04-30 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-19 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-28 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)

Similar Companies
RTSL – Rapid Therapeutic Science Laboratories, Inc. RVLPQ – RVL Pharmaceuticals plc
SCPS – Scopus BioPharma Inc. SEELQ – Seelos Therapeutics, Inc.
SGBI – Sangui Biotech International, Inc.


Financial data and stock pages provided by
Fintel.io